An Open-label, Observational, Long-term Follow-up Study Evaluating the Safety and Efficacy of RGL-193 Putamen Injection in Patients With Primary Parkinson's Disease

Overview

To evaluate the long-term safety of RGL-193 capsid injection in patients with primary Parkinson's disease over 5 years

An open-label, observational, long-term follow-up study evaluating the safety and efficacy of RGL-193 capsid injection in patients with primary Parkinson's disease over 5 years

Conditions

Interventions

Eligibility

Outcomes

Central Contacts